Literature DB >> 25466612

Enhanced recognition of plasma proteins in a non-native state by complement C3b. A possible clearance mechanism for damaged proteins in blood.

Mahalakshmi Ramadass1, Berhane Ghebrehiwet2, Richard R Kew3.   

Abstract

Complement C3 is a key fluid-phase protein of the immune system that covalently tags pathogenic cells and molecules for subsequent clearance. Previously, we reported that complement activation results in the formation of multiple C3b:plasma protein complexes in serum. However, it is not known if C3b attaches to any plasma protein in close proximity or preferentially binds damaged proteins. The objective of this study was to determine if C3b couples to plasma proteins in a non-native state and if this could be a potential mechanism to detect and clear damaged proteins from the blood. Using a purified in vitro system with alternative pathway proteins C3, factors B and D it was observed that guanidinium-HCl denaturation of three purified plasma proteins (albumin, alpha-1 proteinase inhibitor, vitamin D binding protein) greatly increased their capacity to form covalent complexes with C3b. However, native vitamin D binding protein, covalently attached to C3b, still retained the ability to bind its natural ligand G-actin, indicating that C3b links to plasma proteins in their native configuration but denaturation substantially increases this interaction. Serum complement activation generated a large number of C3b:plasma protein complexes that bound red blood cell membranes, suggesting a CR1-mediated clearance mechanism. Thermally denatured (60°C) serum activated the alternative pathway when added to fresh serum as evidenced by factor B cleavage and iC3b generation, but this heat-treated serum could not generate the pro-inflammatory peptide C5a. These results show that C3 recognizes and tags damaged plasma proteins for subsequent removal from the blood without triggering proinflammatory functions.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative pathway activation; Complement C3; Denatured proteins; Extracellular chaperone; Inflammation; Plasma proteins

Mesh:

Substances:

Year:  2014        PMID: 25466612      PMCID: PMC4282830          DOI: 10.1016/j.molimm.2014.10.022

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  33 in total

Review 1.  Phylogenetic aspects of the complement system.

Authors:  I K Zarkadis; D Mastellos; J D Lambris
Journal:  Dev Comp Immunol       Date:  2001 Oct-Dec       Impact factor: 3.636

2.  A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.

Authors:  S Meri; M K Pangburn
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

Review 3.  Proteostasis impairment in protein-misfolding and -aggregation diseases.

Authors:  Mark S Hipp; Sae-Hun Park; F Ulrich Hartl
Journal:  Trends Cell Biol       Date:  2014-06-16       Impact factor: 20.808

4.  Altered conformation of Gc (vitamin D-binding protein) upon complexing with cellular actin.

Authors:  P J Goldschmidt-Clermont; M H Williams; R M Galbraith
Journal:  Biochem Biophys Res Commun       Date:  1987-07-31       Impact factor: 3.575

5.  Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.

Authors:  Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard J Smith; Richard R Kew
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

6.  Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.

Authors:  Tony Wyss-Coray; Fengrong Yan; Amy Hsiu-Ti Lin; John D Lambris; Jessy J Alexander; Richard J Quigg; Eliezer Masliah
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

7.  Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.

Authors:  Y U Kim; M C Carroll; D E Isenman; M Nonaka; P Pramoonjago; J Takeda; K Inoue; T Kinoshita
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

8.  Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.

Authors:  M Kathryn Liszewski; Martin Kolev; Gaelle Le Friec; Marilyn Leung; Paula G Bertram; Antonella F Fara; Marta Subias; Matthew C Pickering; Christian Drouet; Seppo Meri; T Petteri Arstila; Pirkka T Pekkarinen; Margaret Ma; Andrew Cope; Thomas Reinheckel; Santiago Rodriguez de Cordoba; Behdad Afzali; John P Atkinson; Claudia Kemper
Journal:  Immunity       Date:  2013-12-05       Impact factor: 31.745

9.  Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Intracellular sensing of complement C3 activates cell autonomous immunity.

Authors:  Jerry C H Tam; Susanna R Bidgood; William A McEwan; Leo C James
Journal:  Science       Date:  2014-09-04       Impact factor: 47.728

View more
  2 in total

1.  Complement receptor activity of recombinant porcine CR1-like protein expressed in a eukaryotic system.

Authors:  Wei Yin; Xiaoming Wei; Junbing Jiang; Kuohai Fan; Junxing Zhao; Na Sun; Zhiwei Wang; Yaogui Sun; Haili Ma; Xin Zhao; Hongquan Li
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

Review 2.  Challenges in treating Pompe disease: an industry perspective.

Authors:  Hung V Do; Richie Khanna; Russell Gotschall
Journal:  Ann Transl Med       Date:  2019-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.